Trials / Completed
CompletedNCT01328158
Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
Drug Use Investigation of Kaletra Tablets (Quaque Die, QD) on Patients With HIV-infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 236 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study of Kaletra (Lopinavir (LPV)/Ritonavir (RTV)) tablets will be conducted to clarify the following with regard to treatment with this drug: 1. Incidence and conditions of occurrence of adverse reactions in the clinical setting 2. Factors that may affect the safety and effectiveness of Kaletra (QD)
Conditions
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2011-04-04
- Last updated
- 2014-12-22
- Results posted
- 2014-12-22
Locations
23 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01328158. Inclusion in this directory is not an endorsement.